ArticleCancer chemotherapy and pharmacology2019
Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial.
Fernando Rivera et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.